MedTrace Logo

Bacillus Coagulans Effect on Gastrointestinal Function in Healthy Adults.

NCT06644001 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 111

Last updated 2024-10-16

No results posted yet for this study

Summary

A single centre, double-blind, placebo-controlled study to evaluate the effect of the consumption of Bacillus coagulans at a daily dose of 1 x 10⁹ CFU on bowel habits, intestinal microbiota and gastrointestinal symptoms in healthy adults.

Conditions

Interventions

DIETARY_SUPPLEMENT

Bacillus coagulans GBI-30,6086 (BC GBI-30)

2g powder/sachet, consists of bacillus coagulans at a dose of 1x10\^9 CFU, taken once daily before a meal.

DIETARY_SUPPLEMENT

Placebo

2g powder/sachet, consists of maltodextrin only, taken once daily before a meal.

Sponsors & Collaborators

  • Beijing Hospital

    collaborator OTHER_GOV

  • Kerry Group P.L.C

    lead INDUSTRY

Principal Investigators

  • Gang Hu, MD · Beijing Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2021-10-30
Completion
2021-10-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06644001 on ClinicalTrials.gov